403 related articles for article (PubMed ID: 16230400)
1. Alterations of choline phospholipid metabolism in ovarian tumor progression.
Iorio E; Mezzanzanica D; Alberti P; Spadaro F; Ramoni C; D'Ascenzo S; Millimaggi D; Pavan A; Dolo V; Canevari S; Podo F
Cancer Res; 2005 Oct; 65(20):9369-76. PubMed ID: 16230400
[TBL] [Abstract][Full Text] [Related]
2. Molecular causes of the aberrant choline phospholipid metabolism in breast cancer.
Glunde K; Jie C; Bhujwalla ZM
Cancer Res; 2004 Jun; 64(12):4270-6. PubMed ID: 15205341
[TBL] [Abstract][Full Text] [Related]
3. Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells.
Iorio E; Ricci A; Bagnoli M; Pisanu ME; Castellano G; Di Vito M; Venturini E; Glunde K; Bhujwalla ZM; Mezzanzanica D; Canevari S; Podo F
Cancer Res; 2010 Mar; 70(5):2126-35. PubMed ID: 20179205
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models.
Al-Saffar NM; Troy H; RamÃrez de Molina A; Jackson LE; Madhu B; Griffiths JR; Leach MO; Workman P; Lacal JC; Judson IR; Chung YL
Cancer Res; 2006 Jan; 66(1):427-34. PubMed ID: 16397258
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of choline kinase simultaneously attenuates MAPK and PI3K/AKT signaling.
Yalcin A; Clem B; Makoni S; Clem A; Nelson K; Thornburg J; Siow D; Lane AN; Brock SE; Goswami U; Eaton JW; Telang S; Chesney J
Oncogene; 2010 Jan; 29(1):139-49. PubMed ID: 19855431
[TBL] [Abstract][Full Text] [Related]
6. Phosphatidylcholine-specific phospholipase C activation in epithelial ovarian cancer cells.
Spadaro F; Ramoni C; Mezzanzanica D; Miotti S; Alberti P; Cecchetti S; Iorio E; Dolo V; Canevari S; Podo F
Cancer Res; 2008 Aug; 68(16):6541-9. PubMed ID: 18701477
[TBL] [Abstract][Full Text] [Related]
7. Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis.
Katz-Brull R; Seger D; Rivenson-Segal D; Rushkin E; Degani H
Cancer Res; 2002 Apr; 62(7):1966-70. PubMed ID: 11929812
[TBL] [Abstract][Full Text] [Related]
8. Melanoma tumors acquire a new phospholipid metabolism phenotype under cystemustine as revealed by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy of intact tumor samples.
Morvan D; Demidem A; Papon J; De Latour M; Madelmont JC
Cancer Res; 2002 Mar; 62(6):1890-7. PubMed ID: 11912170
[TBL] [Abstract][Full Text] [Related]
9. Detection of neutral active phosphatidylcholine-specific phospholipase C in Friend leukemia cells before and after erythroid differentiation.
Ferretti A; Podo F; Carpinelli G; Chen L; Borghi P; Masella R
Anticancer Res; 1993; 13(6A):2309-17. PubMed ID: 8297151
[TBL] [Abstract][Full Text] [Related]
10. Lidocaine inhibits choline uptake and phosphatidylcholine biosynthesis in human leukemic monocyte-like U937 cells.
Chu AJ; Lee JM
Cell Biochem Funct; 1994 Jun; 12(2):89-98. PubMed ID: 8044894
[TBL] [Abstract][Full Text] [Related]
11. Choline metabolic profiling by magnetic resonance spectroscopy.
Iorio E; Ricci A; Pisanu ME; Bagnoli M; Podo F; Canevari S
Methods Mol Biol; 2013; 1049():255-70. PubMed ID: 23913222
[TBL] [Abstract][Full Text] [Related]
12. [Methyl-3H]-choline incorporation into MCF-7 cells: correlation with proliferation, choline kinase and phospholipase D assay.
Al-Saeedi F; Smith T; Welch A
Anticancer Res; 2007; 27(2):901-6. PubMed ID: 17465218
[TBL] [Abstract][Full Text] [Related]
13. Tumor promoter stimulation of phosphatidylcholine turnover in HeLa cells.
Guy GR; Murray AW
Cancer Res; 1982 May; 42(5):1980-5. PubMed ID: 7066909
[TBL] [Abstract][Full Text] [Related]
14. Phosphatidylcholine metabolism in nuclei of phorbol ester-activated LA-N-1 neuroblastoma cells.
Antony P; Kanfer JN; Freysz L
Neurochem Res; 2000 Aug; 25(8):1073-82. PubMed ID: 11055744
[TBL] [Abstract][Full Text] [Related]
15. Quantification of phosphocholine and glycerophosphocholine with 31P edited 1H NMR spectroscopy.
Loening NM; Chamberlin AM; Zepeda AG; Gonzalez RG; Cheng LL
NMR Biomed; 2005 Nov; 18(7):413-20. PubMed ID: 16075415
[TBL] [Abstract][Full Text] [Related]
16. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells.
Aboagye EO; Bhujwalla ZM
Cancer Res; 1999 Jan; 59(1):80-4. PubMed ID: 9892190
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the cytidine phospholipid pathways in human cancer cells and effects of 1-beta-D-arabinofuranosylcytosine: a noninvasive 31P nuclear magnetic resonance study.
Daly PF; Zugmaier G; Sandler D; Carpen M; Myers CE; Cohen JS
Cancer Res; 1990 Feb; 50(3):552-7. PubMed ID: 2153442
[TBL] [Abstract][Full Text] [Related]
18. Glycerophosphocholine and phosphocholine are the major choline metabolites in rat milk.
Rohlfs EM; Garner SC; Mar MH; Zeisel SH
J Nutr; 1993 Oct; 123(10):1762-8. PubMed ID: 8410369
[TBL] [Abstract][Full Text] [Related]
19. Pyruvate utilization, phosphocholine and adenosine triphosphate (ATP) are markers of human breast tumor progression: a 31P- and 13C-nuclear magnetic resonance (NMR) spectroscopy study.
Singer S; Souza K; Thilly WG
Cancer Res; 1995 Nov; 55(22):5140-5. PubMed ID: 7585561
[TBL] [Abstract][Full Text] [Related]
20. Effect of alkyl-lysophospholipids on phosphatidylcholine biosynthesis in leukemic cell lines.
Vogler WR; Whigham E; Bennett WD; Olson AC
Exp Hematol; 1985 Aug; 13(7):629-33. PubMed ID: 3861326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
